Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1863]
News [4268]
Articles [400]
Editorials [10]
Conferences [107]
elearning [41]
Comment: Sacituzumab govitecan for HR+/HER2‐ advanced breast cancer
Dr Jane Lowe Meisel - Winship Cancer Institute of Emory University, Georgia, USA
Comment: Sacituzumab govitecan for HR+/HER2‐ advanced breast cancer ( Dr Jane Lowe Meisel - Winship Cancer Institute of Emory University, Georgia, USA )
4 Jun 2022
Sacituzumab govitecan increases PFS for HR+/HER2- metastatic breast cancer
Dr Hope Rugo - University of California San Francisco, San Francisco, USA
Sacituzumab govitecan increases PFS for HR+/HER2- metastatic breast cancer ( Dr Hope Rugo - University of California San Francisco, San Francisco, USA )
4 Jun 2022
Cancer Services Delivery: Focus on India
Dr Soumitra Datta - Tata Medical Center, Kolkata, India
Cancer Services Delivery: Focus on India ( Dr Soumitra Datta - Tata Medical Center, Kolkata, India )
26 May 2022
Diagnostic performance and survival outcome of SLNB procedure in breast cancer...
Dr Sanjit Kumar Agrawal - Tata Medical Center, Kolkata, India
Diagnostic performance and survival outcome of SLNB procedure in breast cancer patients from a tertiary cancer care centre ( Dr Sanjit Kumar Agrawal - Tata Medical Center, Kolkata, India )
25 May 2022
War in Ukraine: Impacts on the Ukrainian cancer care system
Dr Andriy Hrynkiv - Lviv Regional Cancer Centre of Ukraine, Lviv, Ukraine
War in Ukraine: Impacts on the Ukrainian cancer care system ( Dr Andriy Hrynkiv - Lviv Regional Cancer Centre of Ukraine, Lviv, Ukraine )
4 May 2022
Recurrent non-invasive breast tumours may not always be related to the primary...
Dr Tanjina Kader - University of Melbourne, Melbourne, Australia
Recurrent non-invasive breast tumours may not always be related to the primary lesion ( Dr Tanjina Kader - University of Melbourne, Melbourne, Australia )
19 Apr 2022
PETRA: Next generation PARP1-selective inhibitor AZD5305 in patients with BRCA1...
Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA
PETRA: Next generation PARP1-selective inhibitor AZD5305 in patients with BRCA1/2, PALB2 or RAD51C/D mutations ( Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA )
13 Apr 2022
Preventive oncology nutrition for healthy carriers and BRCA1/2 + breast cancer...
Dr Diana Artene - American Society for Nutrition, Bucharest, Romania
Preventive oncology nutrition for healthy carriers and BRCA1/2 + breast cancer patients ( Dr Diana Artene - American Society for Nutrition, Bucharest, Romania )
23 Feb 2022
OncoAlert and ecancer weekly round up for February 7th - 13th, 2022
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for February 7th - 13th, 2022 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
17 Feb 2022
Eye metastasis in breast cancer: Case report and review of literature
Dr Ereny Samwel Poles Saad - Assiut University, Asyut, Egypt
Eye metastasis in breast cancer: Case report and review of literature ( Dr Ereny Samwel Poles Saad - Assiut University, Asyut, Egypt )
10 Feb 2022
Update on the new EUSOMA quality indicators for breast cancer
Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal
Update on the new EUSOMA quality indicators for breast cancer ( Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal )
3 Feb 2022
The optimal approach after neoadjuvant treatment: The Lucerne toolbox
Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal
The optimal approach after neoadjuvant treatment: The Lucerne toolbox ( Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal )
3 Feb 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation